About EBC-46
How Does It Work
EBC-46 is delivered in a single treatment by direct injection into tumours, or by topical application of a gel onto the tumour surface, and works by stimulating the patient’s innate immune system to destroy the tumour.
EBC-46 is potentially useful in treating any solid tumour that can be accessed for direct injection of the drug into the tumour. Essentially, any tumour that can be biopsied is amenable for treatment with the drug.
Home
About QBiotics
Snapshot
Business Structure
Our Business Overview
Mission
Strategy
Milestones
Corporate Responsibility
Values & Culture
Governance
Natural Environment
In The Community
About EBC-46
What Is EBC-46
How Does It Work
EBC-46 Discovery
Development
EBC-46 Results
Results
Case Studies
Photo Gallery
Our Team
Board & Management
Research & Development
Partners
Media
Video
Press
Latest News
Media Enquiries
Investors
Register For Upcoming Offers
Download Our Corporate Profile
EBC-46 & Animals
Clinical Trials
Enquiries
EBC-46 & Humans
Clinical Trials
Enquiries
FAQ
Newsletter
Newsletter Sign up
Contact Us
General Enquiries
EBC-46 & Animals
Clinical Trail Enquiries
Media Enquiries